Evaluating Optimal Cost-Effectiveness of Demand Response in Wholesale Markets

被引:0
|
作者
Negash, Ahlmahz I. [1 ]
Westgaard, Sjur [2 ]
机构
[1] Tacoma Power, Energy Resource Planning & Anal, Tacoma, WA 98409 USA
[2] Norwegian Univ Sci & Technol, Ind Econ & Technol Management, Trondheim, Norway
关键词
D O I
暂无
中图分类号
TE [石油、天然气工业]; TK [能源与动力工程];
学科分类号
0807 ; 0820 ;
摘要
Economic demand response (DR) is intended to lower locational marginal prices (LMP) in wholesale energy markets during peak hours. DR resources are paid LMP and that cost is allocated to energy buyers. Market operators use a "net benefits test" to determine if DR is cost effective. This test identifies the LMP threshold below which DR is not cost effective; however, it cannot identify an optimal quantity of DR. Under the current net benefits test, acquisition of "all cost-effective DR" effectively results in a wealth transfer from generators to DR resources and LMPs that are no lower than without DR. Since DR, unlike energy, has no utility, this is not an ideal test of DR cost effectiveness. In this paper, we present a) an alternative method for evaluating the cost effectiveness of economic DR in wholesale markets that makes use of unique DR supply and demand curves, and b) an alternative welfare analysis methodology that identifies maximum social welfare (optimal quantity of DR). We find that because DR has no utility beyond lowering market prices, the optimal quantity of DR does not occur at market equilibrium. Rather, it occurs at the point where potential financial gain from DR is equal to dead weight losses.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] The cost of hydrocephalus: a cost-effectiveness model for evaluating surgical techniques
    Lim, Jaims
    Tang, Alan R.
    Liles, Campbell
    Hysong, Alexander A.
    Hale, Andrew T.
    Bonfield, Christopher M.
    Naftel, Robert P.
    Wellons, John C., III
    Shannon, Chevis N.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2019, 23 (01) : 109 - 118
  • [42] Cost-Effectiveness Analysis in Markets with High Fixed Costs
    Cutler, David M.
    Ericson, Keith M. Marzilli
    PHARMACOECONOMICS, 2010, 28 (10) : 867 - 875
  • [43] Cost-Effectiveness Analysis in Markets with High Fixed Costs
    David M. Cutler
    Keith M. Marzilli Ericson
    PharmacoEconomics, 2010, 28 : 867 - 875
  • [44] On the Cost-effectiveness of Dabigatran. Response
    Gonzalez-Juanatey, Jose R.
    Martinez-Rubio, Antoni
    Gonzalez-Rojas, Nuria
    REVISTA ESPANOLA DE CARDIOLOGIA, 2013, 66 (06): : 513 - 513
  • [45] Cost-effectiveness of Evolocumab. Response
    de Labry Lima, Antonio Olry
    Matas Hoces, Antonio
    Alegre del Rey, Emilio Jesus
    Gimeno Ballester, Vicente
    REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71 (12): : 1090 - 1090
  • [46] Cost-effectiveness in hepatitis B - Response
    Spiegel, BMR
    Martin, P
    Kanwal, F
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (10) : 758 - 759
  • [47] Aerosolized Colistin Cost-effectiveness Response
    Tumbarello, Mario
    De Pascale, Gennaro
    Antonelli, Massimo
    CHEST, 2014, 145 (04) : 927 - 927
  • [48] COST-EFFECTIVENESS OF GENTAMICIN AND TOBRAMYCIN - IN RESPONSE
    HOLLOWAY, JJ
    SMITH, CR
    MOORE, RD
    LIETMAN, PS
    ANNALS OF INTERNAL MEDICINE, 1985, 102 (06) : 867 - 868
  • [49] Cost-effectiveness of current and optimal treatment for schizophrenia
    Andrews, G
    Sanderson, K
    Corry, J
    Issakidis, C
    Lapsley, H
    BRITISH JOURNAL OF PSYCHIATRY, 2003, 183 : 427 - 435
  • [50] Cost-effectiveness of on-demand removal of syndesmotic screws
    D. Penning
    F. R. K. Sanders
    S. van Dieren
    G. R. Roukema
    J. Vermeulen
    J. Winkelhagen
    J. C. Goslings
    T. Schepers
    European Journal of Trauma and Emergency Surgery, 2023, 49 : 921 - 928